These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16521050)

  • 1. A case report of tumor necrosis factor-alpha antibody-induced thrombocytopenia associated with emerging IgM anticardiolipin antibody in patients with scleroderma overlap/rheumatoid arthritis.
    Hamaguchi M; Kawahito Y; Ishino H; Yoshida M; Yoshikawa T
    Clin Rheumatol; 2007 Jun; 26(6):988-90. PubMed ID: 16521050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgG and IgM anticardiolipin antibodies following treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis.
    Visvanathan S; Wagner C; Smolen J; St Clair EW; Hegedus R; Baker D; Keenan G
    Arthritis Rheum; 2006 Sep; 54(9):2840-4. PubMed ID: 16948115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with tumour necrosis factor alpha antagonists in patients with rheumatoid arthritis induces anticardiolipin antibodies.
    Jonsdottir T; Forslid J; van Vollenhoven A; Harju A; Brannemark S; Klareskog L; van Vollenhoven RF
    Ann Rheum Dis; 2004 Sep; 63(9):1075-8. PubMed ID: 15066863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe polymyositis and flare in autoimmunity following treatment with adalimumab in a patient with overlapping features of polyarthritis and scleroderma.
    Liozon E; Ouattara B; Loustaud-Ratti V; Vidal E
    Scand J Rheumatol; 2007; 36(6):484-6. PubMed ID: 18092275
    [No Abstract]   [Full Text] [Related]  

  • 5. Autoantibody formation in patients with rheumatoid arthritis treated with anti-TNF alpha.
    Eriksson C; Engstrand S; Sundqvist KG; Rantapää-Dahlqvist S
    Ann Rheum Dis; 2005 Mar; 64(3):403-7. PubMed ID: 15297281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials.
    Charles PJ; Smeenk RJ; De Jong J; Feldmann M; Maini RN
    Arthritis Rheum; 2000 Nov; 43(11):2383-90. PubMed ID: 11083258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of new-onset psoriasis in a patient receiving infliximab for treatment of rheumatoid arthritis.
    Chan CY; Browning JC; Larsen F; Hsu S
    Dermatol Online J; 2008 Sep; 14(9):12. PubMed ID: 19061594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Segmental vitiligo after infliximab use for rheumatoid arthritis--a case report.
    Carvalho CL; Ortigosa LC
    An Bras Dermatol; 2014; 89(1):154-6. PubMed ID: 24626663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [First scientific meeting of CRI (Rheumatism and Inflammation Club) under the patronage of FNSIM (French National Society of Internal Medicine) and FSR(French Society of Rheumatology) Paris, May 4, 2002].
    Grateau G; Geffray L; Veyssier-Belot C
    Rev Med Interne; 2002 Oct; 23(10):805-7. PubMed ID: 12428480
    [No Abstract]   [Full Text] [Related]  

  • 10. Severe neutropenia and thrombocytopenia associated with infliximab.
    Vidal F; Fontova R; Richart C
    Ann Intern Med; 2003 Aug; 139(3):W-W63. PubMed ID: 12899609
    [No Abstract]   [Full Text] [Related]  

  • 11. Worsening of obstructive sleep apnoeas in a patient with rheumatoid arthritis treated with anti-tumor necrosis factor.
    Zamarrón C; Maceiras F; González J; Gómez-Reino JJ
    Respir Med; 2004 Feb; 98(2):123-5. PubMed ID: 14971874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anticardiolipin antibodies in connective tissue diseases].
    Cerda C; Neira O; Palma S; Abumohor P; Basualdo J; Alvarado MA; Guzmán L
    Rev Med Chil; 1992 Mar; 120(3):239-43. PubMed ID: 1342474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis with interface inflammation and IgG, IgM, and IgA anti-double-stranded DNA antibodies following infliximab therapy: comment on the article by Charles et al.
    Saleem G; Li SC; MacPherson BR; Cooper SM
    Arthritis Rheum; 2001 Aug; 44(8):1966-8. PubMed ID: 11508453
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of interstitial pneumonia in a rheumatoid arthritis patient treated with infliximab, an anti-tumor necrosis factor alpha-neutralizing antibody.
    Mori S; Imamura F; Kiyofuji C; Sugimoto M
    Mod Rheumatol; 2006; 16(4):251-5. PubMed ID: 16906378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extraarticular rheumatoid arthritis and drug-induced syndromes: understanding the role of tumor necrosis factor inhibitors.
    Bruyn GA
    J Rheumatol; 2004 Jul; 31(7):1461; author reply 1462. PubMed ID: 15229972
    [No Abstract]   [Full Text] [Related]  

  • 16. Onset of systemic lupus erythematosus after conversion of infliximab to adalimumab treatment in rheumatoid arthritis with a pre-existing anti-dsDNA antibody level.
    van Rijthoven AW; Bijlsma JW; Canninga-van Dijk M; Derksen RH; van Roon JA
    Rheumatology (Oxford); 2006 Oct; 45(10):1317-9. PubMed ID: 16844698
    [No Abstract]   [Full Text] [Related]  

  • 17. Infliximab-induced discoid lupus erythematosus.
    Cemil BC; Atas H; Canpolat F; Akca Y; Sasmaz R
    Lupus; 2013 Apr; 22(5):515-8. PubMed ID: 23554040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases.
    Merkel PA; Chang Y; Pierangeli SS; Convery K; Harris EN; Polisson RP
    Am J Med; 1996 Dec; 101(6):576-83. PubMed ID: 9003103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactivation of brucellosis after treatment with infliximab in a patient with rheumatoid arthritis.
    Jiménez FG; Colmenero JD; Irigoyen MV
    J Infect; 2005 May; 50(4):370-1. PubMed ID: 15845443
    [No Abstract]   [Full Text] [Related]  

  • 20. Late onset of long-lasting fever as a sole complication of treatment with anti-TNFalpha.
    Tassiopoulos S; Benopoulou O; Mytilineou E; Andreopoulos A; Vaiopoulos G
    Clin Exp Rheumatol; 2005; 23(1):122-3. PubMed ID: 15789902
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.